Pay in 4 interest-free payments of $6.93 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Drug Information Repatha Auto Injector (evolocumab) is an FDA-approved PCSK9 inhibitor for lowering LDL cholesterol and reducing cardiovascular events in adults and children with high cholesterol or familial hypercholesterolemia
In other words, it is possible for patients to maintain weight while stopping the medication but some patients may also gain weight at a faster rate or a greater degree than what is seen in the scientific studies, says Lofton
References 1 EdouardPReurinkGMackeyALLieberRLPizzariTJrvinenTAHet al
honoraria for consultancy from AstraZeneca, Bayer, Boehringer Ingelheim, Novartis, Novo Nordisk and Otsuka
US$ 27.08
US$ 21.74
US$ 29.66
